SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sanjivani Paranteral informs about un-audited financial results

14 Feb 2022 Evaluate

In compliance with Regulation 33 of SEBI (Listing Obligations & Disclosure Requirements) Regulation 2015, Sanjivani Paranteral has informed that it enclosed the copy of Un-Audited Financial Results of the Company for the quarter ended 31st December 2021 together with a copy of the Limited Review Report as received from the Statutory Auditors of the Company. The aforesaid Un-Audited Financial Results were approved / taken on record by the Board of Directors at their meeting held on 14th February 2022. The Board meeting commenced at 01.45 pm and concluded at 02.30 pm.

The above information is a part of company’s filings submitted to BSE.

Sanjivani Paranteral Share Price

163.30 -2.05 (-1.24%)
08-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1847.30
Dr. Reddys Lab 1293.25
Cipla 1347.70
Zydus Lifesciences 938.90
Lupin 2377.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×